Markets enter a massive week marking the unofficial start of Q4 earnings season with major financial institutions including JPMorgan, Bank of America, and Goldman Sachs reporting results.
Meta’s pause on the global rollout of its Ray-Ban Display smart glasses leaves investors to weigh whether META is a buy, sell, or hold at this pivotal moment.
Venezuela-related uncertainty continues to weigh on Chevron shares. Can the Street-high price target hold under these conditions?
The high price estimate for Arcturus suggests the stock can rally as high as 963%. Is it a far-fetched target?
Successful trading involves anticipating what might happen next just as much as reacting to evolving undercurrents.
Using Buffett’s playbook, I screened his portfolio for top dividend payers Wall Street loves, highlighting three businesses suited for long-term income.
Jensen Huang explains artificial intelligence as a multi-layered platform, arguing its true impact extends far beyond consumer-facing language models.
Novo Nordisk shares inch higher as the pharma giant announces an oral Wegovy partnership with Amazon Pharmacy. Here’s why NVO stock is worth owning at current levels.
Opendoor stock soars as President Donald Trump signals his commitment to housing affordability. Here’s why it isn’t worth chasing the rally in OPEN shares today.
OKLO stock rallies as META announces a 1.2 GW nuclear power deal with the small modular reactors company. But can OKLO shares push any higher in 2026?
